Kestra Advisory Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Sell |
2,712
-507
| -16% | -$111K | ﹤0.01% | 1840 |
|
|
2025
Q1 | $721K | Buy |
3,219
+740
| +30% | +$166K | ﹤0.01% | 1589 |
|
|
2024
Q4 | $812K | Buy |
2,479
+234
| +10% | +$76.6K | ﹤0.01% | 1529 |
|
|
2024
Q3 | $674K | Buy |
2,245
+80
| +4% | +$24K | ﹤0.01% | 1563 |
|
|
2024
Q2 | $713K | Buy |
2,165
+274
| +14% | +$90.3K | ﹤0.01% | 1528 |
|
|
2024
Q1 | $748K | Sell |
1,891
-175
| -8% | -$69.2K | 0.01% | 1418 |
|
|
2023
Q4 | $727K | Buy |
2,066
+95
| +5% | +$33.5K | 0.01% | 1289 |
|
|
2023
Q3 | $740K | Sell |
1,971
-158
| -7% | -$59.3K | 0.01% | 1155 |
|
|
2023
Q2 | $814K | Sell |
2,129
-103
| -5% | -$39.4K | 0.01% | 1076 |
|
|
2023
Q1 | $773K | Sell |
2,232
-3,054
| -58% | -$1.06M | 0.01% | 1062 |
|
|
2022
Q4 | $1.24M | Sell |
5,286
-81
| -2% | -$19.1K | 0.01% | 953 |
|
|
2022
Q3 | $1.32M | Sell |
5,367
-95
| -2% | -$23.4K | 0.01% | 837 |
|
|
2022
Q2 | $1.65M | Buy |
5,462
+2,338
| +75% | +$707K | 0.02% | 746 |
|
|
2022
Q1 | $1.28M | Buy |
3,124
+219
| +8% | +$89.9K | 0.01% | 850 |
|
|
2021
Q4 | $1.36M | Buy |
2,905
+244
| +9% | +$114K | 0.01% | 853 |
|
|
2021
Q3 | $1.13M | Buy |
2,661
+201
| +8% | +$85.4K | 0.01% | 954 |
|
|
2021
Q2 | $883K | Sell |
2,460
-13
| -0.5% | -$4.67K | 0.01% | 1004 |
|
|
2021
Q1 | $697K | Buy |
+2,473
| New | +$697K | 0.01% | 1028 |
|